18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
NCT06655545
·
clinicaltrials.gov ↗
COMPLETED
Status
473
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Sponsor
Fudan University